Accumulation of differentiating intestinal stem cell progenies drives tumorigenesis

Stem cell self-renewal and differentiation are coordinated to maintain tissue homeostasis and prevent cancer. Mutations causing stem cell proliferation are traditionally the focus of cancer studies. However, the contribution of the differentiating stem cell progenies in tumorigenesis is poorly chara...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhai, Zongzhao (Author) , Kondo, Shu (Author) , Ha, Nati (Author) , Boquete, Jean-Philippe (Author) , Brunner, Michael (Author) , Ueda, Ryu (Author) , Lemaitre, Bruno (Author)
Format: Article (Journal)
Language:English
Published: 22 Dec 2015
In: Nature Communications
Year: 2015, Volume: 6, Pages: 1-13
ISSN:2041-1723
DOI:10.1038/ncomms10219
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/ncomms10219
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/ncomms10219
Get full text
Author Notes:Zongzhao Zhai, Shu Kondo, Nati Ha, Jean-Philippe Boquete, Michael Brunner, Ryu Ueda & Bruno Lemaitre
Description
Summary:Stem cell self-renewal and differentiation are coordinated to maintain tissue homeostasis and prevent cancer. Mutations causing stem cell proliferation are traditionally the focus of cancer studies. However, the contribution of the differentiating stem cell progenies in tumorigenesis is poorly characterized. Here we report that loss of the SOX transcription factor, Sox21a, blocks the differentiation programme of enteroblast (EB), the intestinal stem cell progeny in the adult Drosophila midgut. This results in EB accumulation and formation of tumours. Sox21a tumour initiation and growth involve stem cell proliferation induced by the unpaired 2 mitogen released from accumulating EBs generating a feed-forward loop. EBs found in the tumours are heterogeneous and grow towards the intestinal lumen. Sox21a tumours modulate their environment by secreting matrix metalloproteinase and reactive oxygen species. Enterocytes surrounding the tumours are eliminated through delamination allowing tumour progression, a process requiring JNK activation. Our data highlight the tumorigenic properties of transit differentiating cells.
Item Description:Gesehen am 23.07.2020
Physical Description:Online Resource
ISSN:2041-1723
DOI:10.1038/ncomms10219